Search Results - "Scott, Tara E."

Animal models of pulmonary hypertension: Getting to the heart of the problem by Dignam, Joshua P., Scott, Tara E., Kemp‐Harper, Barbara K., Hobbs, Adrian J.

“…Despite recent therapeutic advances, pulmonary hypertension (PH) remains a fatal disease due to the development of right ventricular (RV) failure. At present,…”
Get full text

IL-4 and IL-13 induce equivalent expression of traditional M2 markers and modulation of reactive oxygen species in human macrophages by Scott, Tara E., Lewis, Caitlin V., Zhu, Mingyu, Wang, Chao, Samuel, Chrishan S., Drummond, Grant R., Kemp-Harper, Barbara K.

“…In cardiovascular disease, pathological and protective roles are reported for the Th2 cytokines IL-4 and IL-13, respectively. We hypothesised that differential…”
Get full text

Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis by Pinar, Anita A., Scott, Tara E., Huuskes, Brooke M., Tapia Cáceres, Felipe E., Kemp-Harper, Barbara K., Samuel, Chrishan S.

“…Cardiovascular fibrosis refers to the scar tissue that develops in the injured heart and blood vessels from an aberrant wound healing response to organ injury…”
Get full text

Innovative Anti-Inflammatory and Pro-resolving Strategies for Pulmonary Hypertension: High Blood Pressure Research Council of Australia Award 2019 by Scott, Tara E., Qin, Cheng Xue, Drummond, Grant R., Hobbs, Adrian J., Kemp-Harper, Barbara K.

“…Pulmonary hypertension is a rare, ostensibly incurable, and etiologically diverse disease with an unacceptably high 5-year mortality rate (≈50%), worse than…”
Get full text

Innovative Anti-Inflammatory and Pro-resolving Strategies for Pulmonary Hypertension: High Blood Pressure Research Council of Australia Award 2019 by Scott, Tara E., Qin, Cheng Xue, Drummond, Grant R., Hobbs, Adrian J., Kemp-Harper, Barbara K.

“…Pulmonary hypertension is a rare, ostensibly incurable, and etiologically diverse disease with an unacceptably high 5-year mortality rate (≈50%), worse than…”
Get full text